Tapewire

Nasdaq · USD

ATEC

Alphatec Holdings, Inc.

Export transactions ↓
Tapewire entity
4720
SEC CIK
0001350653
Parsed reports
552

Last 12 months

Inside the activity.

4 purchase rows · 41 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025012
Dec 2025018
Jan 202601
Feb 202602
Mar 202606
Apr 202600
May 202630
Jun 202601
Jul 202600
Aug 202601
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 17, 2021 Filed Jun 22, 2021 19:51 UTC GrantCommon Stock 20,467 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006957 · edgar.xml · nonDerivative · entry 2

Meynadier Marie · CIK 0001868954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,672

F2 · security: On June 17, 2021, issuer also granted to the reporting person 20,467 restricted stock units which vest in three equal installments on each of June 17, 2022, June 17, 2023, and June 17, 2024.

F3 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock.

F2 · shares: On June 17, 2021, issuer also granted to the reporting person 20,467 restricted stock units which vest in three equal installments on each of June 17, 2022, June 17, 2023, and June 17, 2024.

F2 · balance_after: On June 17, 2021, issuer also granted to the reporting person 20,467 restricted stock units which vest in three equal installments on each of June 17, 2022, June 17, 2023, and June 17, 2024.

Read SEC document
June 17, 2021 Filed Jun 22, 2021 19:51 UTC GrantCommon Stock 10,205 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006957 · edgar.xml · nonDerivative · entry 1

Meynadier Marie · CIK 0001868954 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,205

F1 · security: On June 17, 2021, issuer granted to the reporting person 10,205 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F3 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock.

F1 · shares: On June 17, 2021, issuer granted to the reporting person 10,205 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 17, 2021, issuer granted to the reporting person 10,205 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 16, 2021 21:39 UTC
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
Exercise / conversionWarrants to Purchase Common Stock · Derivative 400,000 $0.00 Strike: $3.50 $0.00
Disclosure

SEC source: 0001567619-21-012222 · doc1.xml · derivative · entry 3

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,346,032

Underlying: Common Stock · 400,000 shares

Expires 2023-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

Read SEC document
June 16, 2021 Filed Jun 16, 2021 21:39 UTC
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
Tax withholdingCommon Stock 93,747 $14.93 $1,399,642.71
Disclosure

SEC source: 0001567619-21-012222 · doc1.xml · nonDerivative · entry 2

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,242,761

F3 · shares: Represents a "cashless exercise" of outstanding warrants. The reporting person received 306,253 shares of Common Stock on cashless exercise of warrants to purchase 400,000 shares of Common Stock. The Company withheld 93,747 shares of Common Stock underlying the warrants for payment of the exercise price, using the VWAP on June 15, 2021 of $14.93, pursuant to the terms of the warrant.

F1 · ownership.direct: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

Read SEC document
June 16, 2021 Filed Jun 16, 2021 21:39 UTC
L-5 Healthcare Partners, LLC10% owner · Director by deputization
Segal Paul10% owner · Director by deputization
Exercise / conversionCommon Stock 400,000 $3.50 $1,400,000.00
Disclosure

SEC source: 0001567619-21-012222 · doc1.xml · nonDerivative · entry 1

L-5 Healthcare Partners, LLC · CIK 0001733085 · 10% owner · Director by deputization

Segal Paul · CIK 0001427470 · 10% owner · Director by deputization

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,336,508

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.direct: Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.

F2 · ownership.direct: Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 18:15 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006868 · edgar.xml · nonDerivative · entry 1

Blackford Quentin S. · CIK 0001612451 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 524,151

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 14:16 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006871 · edgar.xml · nonDerivative · entry 1

Mowry David H · CIK 0001414301 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,051

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 14:15 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006870 · edgar.xml · nonDerivative · entry 1

MCGINNIS KAREN K · CIK 0001188264 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,660

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 14:16 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006873 · edgar.xml · nonDerivative · entry 1

WOODS WARD W JR · CIK 0001196931 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,959

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 18:14 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006866 · edgar.xml · nonDerivative · entry 1

TULLIS JAMES L L · CIK 0001230641 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,090

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 14:16 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006872 · edgar.xml · nonDerivative · entry 1

Rydin Jeffrey P · CIK 0001345767 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 425,109

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 18:17 UTC
Sponsel DavidEVP, Sales
SaleCommon Stock 10,000 $14.78 $147,800.00
Disclosure

SEC source: 0001179110-21-006875 · edgar.xml · nonDerivative · entry 1

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 554,317

Read SEC document
June 16, 2021 Filed Jun 21, 2021 22:29 UTC
Pelizzon David RDirector · 10% owner
GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-025076 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 279,058

F1 · shares: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

F1 · price: On June 16, 2021, the Issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest on the 12 month anniversary of the grant date.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 18:17 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006874 · edgar.xml · nonDerivative · entry 1

Williams Donald Allen · CIK 0001620013 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,728

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 18:15 UTC GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006869 · edgar.xml · nonDerivative · entry 1

Hochberg Jason · CIK 0001392348 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,375

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 18:14 UTC
Bakst EvanDirector
GrantCommon Stock 10,221 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-006867 · edgar.xml · nonDerivative · entry 1

Bakst Evan · CIK 0001733939 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 776,361

F1 · security: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · shares: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · price: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

F1 · balance_after: On June 16, 2021, issuer granted to the reporting person 10,221 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rated based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.

Read SEC document
May 17, 2021 Filed May 19, 2021 16:41 UTC
Snider BrianEVP, Strat. Mktg. & Prod. Dev.
Tax withholdingCommon Stock 21,982 $14.81 $325,553.42
Disclosure

SEC source: 0001179110-21-005571 · edgar.xml · nonDerivative · entry 1

Snider Brian · CIK 0001702383 · EVP, Strat. Mktg. & Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 619,190

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F2 · balance_after: Includes 1,510 shares acquired under the issuer's employee stock purchase plan on May 14, 2021.

Read SEC document
May 17, 2021 Filed May 19, 2021 16:40 UTC
Howell Kelli MariEVP, Clinical Strategies
Tax withholdingCommon Stock 17,525 $14.81 $259,545.25
Disclosure

SEC source: 0001179110-21-005569 · edgar.xml · nonDerivative · entry 1

Howell Kelli Mari · CIK 0001734485 · EVP, Clinical Strategies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 497,449

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F2 · balance_after: Includes 2,507 shares acquired under the issuer's employee stock purchase plan on May 14, 2021.

Read SEC document
May 17, 2021 Filed May 19, 2021 16:29 UTC
Sponsel DavidEVP, Sales
Tax withholdingCommon Stock 34,087 $14.81 $504,828.47
Disclosure

SEC source: 0001179110-21-005568 · edgar.xml · nonDerivative · entry 1

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 564,317

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F2 · balance_after: Includes 220 shares acquired under the issuer's employee stock purchase plan on May 14, 2021.

Read SEC document
May 17, 2021 Filed May 19, 2021 16:28 UTC
Hunsaker Craig EEVP, People/Culture & GC
Tax withholdingCommon Stock 28,271 $14.81 $418,693.51
Disclosure

SEC source: 0001179110-21-005567 · edgar.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,051,869

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:56 UTC PurchaseCommon Stock 1,000 $14.50 $14,500.00
Disclosure

SEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 4

Pritzker Jennifer N. · CIK 0001850165 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,000

F4 · ownership.nature: These shares are held by the Pritzker Military Foundation. As the sole member of the Pritzker Military Foundation, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:56 UTC PurchaseCommon Stock 1,000 $14.50 $14,500.00
Disclosure

SEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 3

Pritzker Jennifer N. · CIK 0001850165 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,000

F3 · ownership.nature: These shares are held by the Tawani Foundation. As the sole member of the Tawani Foundation, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:56 UTC PurchaseCommon Stock 1,000 $14.50 $14,500.00
Disclosure

SEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 2

Pritzker Jennifer N. · CIK 0001850165 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,000

F2 · ownership.nature: These shares are held by the Pritzker Military Museum and Library ("PMML"). As the sole member of PMML, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of her pecuniary interest therein.

Read SEC document
May 10, 2021 Filed May 12, 2021 21:56 UTC PurchaseCommon Stock 4,000 $14.38 $57,520.00
Disclosure

SEC source: 0000899243-21-019288 · doc4.xml · nonDerivative · entry 1

Pritzker Jennifer N. · CIK 0001850165 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,200

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.37 to $14.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1).

Read SEC document
May 10, 2021 Filed May 12, 2021 21:25 UTC
Pelizzon David RDirector · 10% owner
PurchaseCommon Stock 120,000 $15.25 $1,830,000.00
Disclosure

SEC source: 0000899243-21-019280 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,837

Read SEC document
May 03, 2021 Filed May 5, 2021 00:10 UTC
Sponsel DavidEVP, Sales
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 12,813 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001179110-21-004879 · edgar.xml · derivative · entry 5

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,187

Underlying: Common Stock · 12,813 shares

Expires 2028-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vest 25% on November 2, 2019 and thereafter in 36 equal monthly installments.

Read SEC document
May 03, 2021 Filed May 5, 2021 00:10 UTC
Sponsel DavidEVP, Sales
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 17,187 $0.00 Strike: $3.86 $0.00
Disclosure

SEC source: 0001179110-21-004879 · edgar.xml · derivative · entry 4

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,813

Underlying: Common Stock · 17,187 shares

Expires 2028-05-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options vest 25% on May 29, 2019 and thereafter in 36 equal monthly installments.

Read SEC document
May 03, 2021 Filed May 5, 2021 00:10 UTC
Sponsel DavidEVP, Sales
SaleCommon Stock 30,000 $15.97 $479,100.00
Disclosure

SEC source: 0001179110-21-004879 · edgar.xml · nonDerivative · entry 3

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 598,184

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
May 03, 2021 Filed May 5, 2021 00:10 UTC
Sponsel DavidEVP, Sales
Exercise / conversionCommon Stock 12,813 $3.17 $40,617.21
Disclosure

SEC source: 0001179110-21-004879 · edgar.xml · nonDerivative · entry 2

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 628,184

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2021 Filed May 5, 2021 00:10 UTC
Sponsel DavidEVP, Sales
Exercise / conversionCommon Stock 17,187 $3.86 $66,341.82
Disclosure

SEC source: 0001179110-21-004879 · edgar.xml · nonDerivative · entry 1

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 615,371

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 29, 2021 Filed May 3, 2021 12:42 UTC
Miles PatrickDirector · CEO
Tax withholdingCommon Stock 146,074 $16.33 $2,385,388.42
Disclosure

SEC source: 0001179110-21-004762 · edgar.xml · nonDerivative · entry 1

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,958,775

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

Read SEC document
April 29, 2021 Filed May 3, 2021 16:44 UTC
Hunsaker Craig EEVP, People/Culture & GC
Tax withholdingCommon Stock 22,381 $16.33 $365,481.73
Disclosure

SEC source: 0001179110-21-004765 · edgar.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,080,140

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

Read SEC document
April 29, 2021 Filed May 3, 2021 16:43 UTC
Snider BrianEVP, Strat. Mktg. & Prod. Dev.
Tax withholdingCommon Stock 20,080 $16.33 $327,906.40
Disclosure

SEC source: 0001179110-21-004764 · edgar.xml · nonDerivative · entry 1

Snider Brian · CIK 0001702383 · EVP, Strat. Mktg. & Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 639,662

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

Read SEC document
April 29, 2021 Filed May 3, 2021 16:42 UTC
Howell Kelli MariEVP, Clinical Strategies
Tax withholdingCommon Stock 11,474 $16.33 $187,370.42
Disclosure

SEC source: 0001179110-21-004763 · edgar.xml · nonDerivative · entry 1

Howell Kelli Mari · CIK 0001734485 · EVP, Clinical Strategies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 512,467

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

Read SEC document
April 26, 2021 Filed Apr 28, 2021 13:52 UTC
Sponsel DavidEVP, Sales
SaleCommon Stock 14,572 $16.63 $242,332.36
Disclosure

SEC source: 0001179110-21-004643 · edgar.xml · nonDerivative · entry 1

Sponsel David · CIK 0001772837 · EVP, Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 598,184

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.42 to $16.84, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
April 19, 2021 Filed Apr 21, 2021 14:26 UTC
Koning John ToddChief Financial Officer
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-004531 · edgar.xml · nonDerivative · entry 2

Koning John Todd · CIK 0001830843 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,000

F2 · security: On April 19, 2021, the issuer also granted to the reporting person 40,000 RSUs, which vest in three equal installments on each of February 18, 2022, February 18, 2023, and February 18, 2024.

F3 · security: Each RSU represents a contingent right to receive one share of the issuer's common stock.

F2 · shares: On April 19, 2021, the issuer also granted to the reporting person 40,000 RSUs, which vest in three equal installments on each of February 18, 2022, February 18, 2023, and February 18, 2024.

F2 · balance_after: On April 19, 2021, the issuer also granted to the reporting person 40,000 RSUs, which vest in three equal installments on each of February 18, 2022, February 18, 2023, and February 18, 2024.

Read SEC document
April 19, 2021 Filed Apr 21, 2021 14:26 UTC
Koning John ToddChief Financial Officer
GrantCommon Stock 150,000 $0.00 $0.00
Disclosure

SEC source: 0001179110-21-004531 · edgar.xml · nonDerivative · entry 1

Koning John Todd · CIK 0001830843 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

F1 · security: On April 19, 2021, the issuer granted to the reporting person 150,000 restricted stock units (RSUs), which vest in four equal installments on each of the first four anniversaries of the grant date.

F3 · security: Each RSU represents a contingent right to receive one share of the issuer's common stock.

F1 · shares: On April 19, 2021, the issuer granted to the reporting person 150,000 restricted stock units (RSUs), which vest in four equal installments on each of the first four anniversaries of the grant date.

F1 · balance_after: On April 19, 2021, the issuer granted to the reporting person 150,000 restricted stock units (RSUs), which vest in four equal installments on each of the first four anniversaries of the grant date.

Read SEC document
April 12, 2021 Filed Apr 12, 2021 20:13 UTC
Hunsaker Craig EEVP, People/Culture & GC
Exercise / conversionWarrants (right to buy) · Derivative 100,000 $0.00 Strike: $2.00 $0.00
Disclosure

SEC source: 0001179110-21-004374 · edgar.xml · derivative · entry 4

Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2022-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 12, 2021 Filed Apr 12, 2021 20:13 UTC
Hunsaker Craig EEVP, People/Culture & GC
Exercise / conversionCommon Stock 100,000 $2.00 $200,000.00
Disclosure

SEC source: 0001179110-21-004374 · edgar.xml · nonDerivative · entry 3

Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,102,521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 09, 2021 Filed Apr 12, 2021 20:13 UTC
Hunsaker Craig EEVP, People/Culture & GC
SaleCommon Stock 5,840 $18.00 $105,120.00
Disclosure

SEC source: 0001179110-21-004374 · edgar.xml · nonDerivative · entry 2

Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,002,521

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021.

Read SEC document
April 08, 2021 Filed Apr 12, 2021 20:13 UTC
Hunsaker Craig EEVP, People/Culture & GC
SaleCommon Stock 25,000 $16.23 $405,750.00
Disclosure

SEC source: 0001179110-21-004374 · edgar.xml · nonDerivative · entry 1

Hunsaker Craig E · CIK 0001509282 · EVP, People/Culture & GC

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,008,361

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.89 to $16.54, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
March 25, 2021 Filed Mar 26, 2021 22:38 UTC
Snider BrianEVP, Strat. Mktg. & Prod. Dev.
Tax withholdingCommon Stock 6,484 $16.68 $108,153.12
Disclosure

SEC source: 0001179110-21-003833 · edgar.xml · nonDerivative · entry 1

Snider Brian · CIK 0001702383 · EVP, Strat. Mktg. & Prod. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 659,742

F1 · kind: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · shares: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

F1 · balance_after: Shares withheld by issuer to satisfy tax withholding obligations of reporting person resulting from vesting of restricted stock units.

Read SEC document
March 11, 2021 Filed Feb 10, 2022 20:36 UTC
Miles PatrickDirector · CEO
GiftCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001179110-22-001030 · edgar.xml · nonDerivative · entry 1

Miles Patrick · CIK 0001289409 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,026,394

Read SEC document
March 10, 2021 Filed Mar 12, 2021 23:57 UTC PurchaseCommon Stock 1,000 $16.31 $16,310.00
Disclosure

SEC source: 0000899243-21-011377 · doc4.xml · nonDerivative · entry 3

Pritzker Jennifer N. · CIK 0001850165 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,200

Read SEC document
March 10, 2021 Filed Mar 12, 2021 23:57 UTC PurchaseCommon Stock 1,000 $16.42 $16,420.00
Disclosure

SEC source: 0000899243-21-011377 · doc4.xml · nonDerivative · entry 2

Pritzker Jennifer N. · CIK 0001850165 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,200

Read SEC document
March 10, 2021 Filed Mar 12, 2021 23:57 UTC PurchaseCommon Stock 1,000 $16.40 $16,400.00
Disclosure

SEC source: 0000899243-21-011377 · doc4.xml · nonDerivative · entry 1

Pritzker Jennifer N. · CIK 0001850165 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,200

Read SEC document
March 09, 2021 Filed Mar 10, 2021 21:14 UTC SaleCommon Stock 7,000 $16.69 $116,830.00
Disclosure

SEC source: 0001179110-21-003246 · edgar.xml · nonDerivative · entry 1

Black Jeffrey G. · CIK 0001449439 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 620,770

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019, as amended November 27, 2020, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of previously granted restricted stock unit awards.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.12 to $17.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
March 09, 2021 Filed Mar 12, 2021 01:20 UTC SaleCommon Stock 22,500 $16.24 $365,400.00
Disclosure

SEC source: 0001179110-21-003288 · edgar.xml · nonDerivative · entry 1

TULLIS JAMES L L · CIK 0001230641 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Tullis Growth Fund, L.P.

Disclosed balance after: 545,747

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.27, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
March 08, 2021 Filed Mar 10, 2021 21:48 UTC
Pelizzon David RDirector · 10% owner
PurchaseCommon Stock 695 $15.93 $11,071.35
Disclosure

SEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 2

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,837

Read SEC document
March 08, 2021 Filed Mar 10, 2021 21:48 UTC
Pelizzon David RDirector · 10% owner
PurchaseCommon Stock 4,003 $15.50 $62,046.50
Disclosure

SEC source: 0000899243-21-010986 · doc4.xml · nonDerivative · entry 1

Pelizzon David R · CIK 0001719217 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,142

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.